Enanta Pharmaceuticals
ENTA
#8068
Rank
NZ$0.67 B
Marketcap
NZ$23.05
Share price
0.93%
Change (1 day)
30.15%
Change (1 year)

Enanta Pharmaceuticals (ENTA) - Cash on Hand

Cash on Hand as of June 2026 : NZ$0.33 Billion

According to Enanta Pharmaceuticals 's latest financial reports the company has NZ$0.33 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Enanta Pharmaceuticals - Cash on Hand chart (from 2011 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-09-30NZ$0.32 B-16.69%
2024-09-30NZ$0.39 B-36.61%
2023-09-30NZ$0.61 B39.55%
2022-09-30NZ$0.44 B24.97%
2021-09-30NZ$0.35 B-39.4%
2020-09-30NZ$0.58 B9.06%
2019-09-30NZ$0.53 B14.85%
2018-09-30NZ$0.46 B49.86%
2017-09-30NZ$0.31 B7.48%
2016-09-30NZ$0.28 B27.33%
2015-09-30NZ$0.22 B95.53%
2014-09-30NZ$0.11 B-4.99%
2013-09-30NZ$0.12 B131.41%
2012-09-30NZ$52.86 M73.91%
2011-09-30NZ$30.39 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Johnson & Johnson
JNJ
NZ$36.91 B 10,853.74%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
NZ$13.67 B 3,957.92%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
AbbVie
ABBV
NZ$11.68 B 3,366.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Vertex Pharmaceuticals
VRTX
NZ$13.96 B 4,043.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
NZ$12.69 B 3,668.22%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
NZ$19.68 B 5,739.92%๐Ÿ‡บ๐Ÿ‡ธ USA